Fulphila 6 mg
Fulphila 6 mg is a medicine authorised by Swissmedic under authorisation number 67478. The authorisation holder is Medius AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 29 January 2020 and the authorisation is valid without a time limit. ATC code L03AA13 places the medicine in the group Immunostimulants.
| Authorisation number | 67478 |
|---|---|
| Name | Fulphila 6 mg |
| Full name | Fulphila 6 mg, Injektionslösung |
| Authorisation holder | Medius AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L03AA13 |
| First authorisation | 29 January 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Fulphila 6 mg, Injektionslösung | A | 29 January 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x | Fertigspritze(n) | L03AA13 | 06.07.3. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Fulphila 6 mg authorised in Switzerland?
Yes. Fulphila 6 mg is authorised by Swissmedic under authorisation number 67478, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Fulphila 6 mg have?
Fulphila 6 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Fulphila 6 mg?
The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.